vimarsana.com

Page 8 - Cell Line Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cell Line Development Market Size Worth $12 09 Bn, Globally, by 2028 Growing at 8 7% | Global Industry Analysis, Market Size, Opportunities and Forecast

Cell Line Development Market Size Worth $12.09 Bn, Globally, by 2028 Growing at 8.7%. | Global Industry Analysis, Market Size, Opportunities and Forec

United statesSaudi arabiaRepublic ofNew zealandCzech republicSouth koreaSouth africaAsia pacificResearch newswireThermo fisher scientific incGe healthcareIntrospective market researchAldrich corporationGlobal cell line development industryLonza group ag switzerlandPromega corporation

Xtalks Announces its Life Science Webinar Calendar for June 2023

Toronto, ON (PRWEB) June 02, 2023 Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical

Population healthPractices in clinical gene therapy method developmentPrecision research ecosystem for realHoneycomb worldwide incTb vaccine developmentOptimal cell line developmentCart development programsInnovative technologyBuilding in solutionsGlobal regulatory challenges in coPreclinical developmentDigital pathology in preclinical rd servicesManufacturers when selectinga lab testing partnerDrug developmentClinical trial assay development for precision medicineStage development

Screening and isolating rare cells with assured clonality

In this article, Sphere Fluidics showcases a method by which to screen and isolate high value rare cells that possess assured clonality.

United kingdomAlex smithUniversity of cambridgeCollaborative servicesCell line developmentOur technology access programmesLife sciencesSponsored contentSphere fluidicsmayNew drug applicationSingle cell analysisMonoclonality assurance systemImage creditHigh fidelity modeIgg secretion assayAntigen specific assay

Automating CRISPR-based cell line development

Increased demands for faster high-throughput CRISPR-based cell-line development and improved pharmaceutical screening are encouraging research facilities and companies to automate their labs.

United kingdomAimee molineuxAnn clin biochemKo santa cruzIt labClin chem labMolecular devices united kingdom ltdBiopharm internationalLine developmentRev clin labSponsored contentMolecular devices united kingdom ltdmayClone select imagerMolecular devices united kingdomImage creditSanta cruz biotechnology

ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti RiGHT™ - A Shortcut to Successful Lent

BOSTON, MA, USA and BERLIN, Germany, May 17, 2023 / B3C newswire /  ProBioGen today announced the launch of their lentivirus (LV) packaging cell line Lenti.RiGHT™ as a new platinum standard for LV production at this year's PEGS Boston 2023. The lentivirus production platform is based on HEK293 packaging cells.

United statesGabriele schneiderVolker sandigSarah wandreyDrug developmentDelivery of health careCorporate communicationsCell line developmentProbiogen press contactChief scientific officerChimeric antigenHealth careIndustrial facilitiesCell lineCell culture techniquesCulture media

vimarsana © 2020. All Rights Reserved.